Journal of Biological Chemistry · 1996 · 362 citations · 31 references
Life SciencesBiochemistryMolecular BiologyBreast OncologyGlycobiologyMolecular OncologyCancer GlycobiologyCell-surface GlycansGlycan AnalysisGlycan LabelingGlycan StructureO-linked GlycosylationAberrant Glycosylation In CancerAberrant O-glycosylation In CancerAnion ChromatographyMucin AntigensMucin Glycan AnalysisMucin GlycoproteinsMucin-type Glycans In CancerMucin-type O-glycosylation
MUC-1 mucin is considered to be aberrantly glycosylated in breast, ovary, and other carcinomas in comparison with mucin from corresponding normal tissues. In order to clarify these differences in glycosylation, we have compared the O-linked carbohydrate chains from MUC-1 immunoprecipitated from [3H]GlcN-labeled breast epithelial cell lines (MMSV1-1, MTSV1-7, and HB-2) derived from cells cultured from human milk, with three breast cancer cell lines (MCF-7, BT-20, and T47D). Analysis by high pH anion chromatography showed that the normal cell lines had a higher ratio of GlcN/GalN and more complex oligosaccharide profiles than the cancer cell lines. Structural analyses were carried out on the oligosaccharides from MTSV1-7 and T47D MUC-1, and the following structures were proposed. MUC-1 from T47D had rather a simple glycosylation pattern, with NeuAcα2-3Galβ1-3GalNAc-ol, Galβ1-3GalNAc-ol, and GalNAc-ol predominating; in contrast, MUC-1 from MTSV1-7 had more complex structures, including a number of disialo, core 2 species, i.e. NeuAcα2-3Galβ1-4GlcNAcβ1-6[NeuAcα2-3Galβ1-3]GalNAc-ol and NeuAcα2-3Galβ1-4GlcNAcβ1-6[NeuAcα2-3Galβ1-4GlcNAcβ1-3Galβ1-3]GalNAc-ol. Double-labeling experiments with [3H]GlcN and 14C-aminoacids and analysis of GalNAc or GalNAc-ol:protein ratios in MUC-1 showed that there was also a significant difference in the degree of glycosylation of the mucin between the two cell types. We conclude that MUC-1 from breast cancer cell lines has simpler, and fewer, carbohydrate chains than MUC-1 from normal breast epithelial cells, and that these differences, combined or separately, explain the differential tumor specificity of some MUC-1 antibodies and T cells. MUC-1 mucin is considered to be aberrantly glycosylated in breast, ovary, and other carcinomas in comparison with mucin from corresponding normal tissues. In order to clarify these differences in glycosylation, we have compared the O-linked carbohydrate chains from MUC-1 immunoprecipitated from [3H]GlcN-labeled breast epithelial cell lines (MMSV1-1, MTSV1-7, and HB-2) derived from cells cultured from human milk, with three breast cancer cell lines (MCF-7, BT-20, and T47D). Analysis by high pH anion chromatography showed that the normal cell lines had a higher ratio of GlcN/GalN and more complex oligosaccharide profiles than the cancer cell lines. Structural analyses were carried out on the oligosaccharides from MTSV1-7 and T47D MUC-1, and the following structures were proposed. MUC-1 from T47D had rather a simple glycosylation pattern, with NeuAcα2-3Galβ1-3GalNAc-ol, Galβ1-3GalNAc-ol, and GalNAc-ol predominating; in contrast, MUC-1 from MTSV1-7 had more complex structures, including a number of disialo, core 2 species, i.e. NeuAcα2-3Galβ1-4GlcNAcβ1-6[NeuAcα2-3Galβ1-3]GalNAc-ol and NeuAcα2-3Galβ1-4GlcNAcβ1-6[NeuAcα2-3Galβ1-4GlcNAcβ1-3Galβ1-3]GalNAc-ol. Double-labeling experiments with [3H]GlcN and 14C-aminoacids and analysis of GalNAc or GalNAc-ol:protein ratios in MUC-1 showed that there was also a significant difference in the degree of glycosylation of the mucin between the two cell types. We conclude that MUC-1 from breast cancer cell lines has simpler, and fewer, carbohydrate chains than MUC-1 from normal breast epithelial cells, and that these differences, combined or separately, explain the differential tumor specificity of some MUC-1 antibodies and T cells.
31
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Herbert D. Soule, J. Vázquez, Anna Long et al. · JNCI Journal of the National Cancer Institute · 1973 · 2.5K citations
Medicine, Cell Biology, Oncology +10
Methods in Carbohydrate Chemistry
J. S. Brimacombe · Carbohydrate Research · 1994 · 1.2K citations
Joyce Taylor‐Papadimitriou, Jerry A. Peterson, J. Arklie et al. · International Journal of Cancer · 1981 · 604 citations